Emergent BioSolutions (EBS) Change in Taxes (2022 - 2026)
Emergent BioSolutions (EBS) posted quarterly Change in Taxes of $4.6 million for Q1 2026, up 154.76% year-over-year from $1.8 million in Q1 2025, and up 173.02% quarter-over-quarter from -$6.3 million in Q4 2025.
Emergent BioSolutions (EBS) Change in Taxes (2022 - 2026) Analysis & Trends
Emergent BioSolutions' Change in Taxes history runs 5 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- In Q1 2026, Change in Taxes rose 154.76% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $11.3 million (up 1041.67% YoY), while the FY2025 annual figure was -$1.7 million, down 107.3% from the prior year.
- Change in Taxes for Q1 2026 stood at $4.6 million, up from -$6.3 million in the prior quarter.
- The five-year high for Change in Taxes was $79.7 million in Q4 2022, with the low at -$40.9 million in Q2 2022.
- The 5-year median for Change in Taxes is -$0.0 (2024), against an average of $2.3 million.
- The sharpest annual moves came in 2023 and 2025: Change in Taxes sank 284.78% in 2023, then surged 3.650722201600001e+17% in 2025.
- Emergent BioSolutions' Change in Taxes stood at $79.7 million in 2022, then sank by 115.93% to -$12.7 million in 2023, then surged by 74.02% to -$3.3 million in 2024, then sank by 90.91% to -$6.3 million in 2025, then surged by 173.02% to $4.6 million in 2026.
- Business Quant data shows EBS's Change in Taxes at $4.6 million in Q1 2026, -$6.3 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -300,000.00 |
| Jun 30, 2026 | -300,000.00 |
| Mar 31, 2026 | 4.60 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | -6.30 Mn |
| Dec 31, 2025 | -6.30 Mn |
| Sep 30, 2025 | 6.20 Mn |
| Sep 30, 2025 | 6.20 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Mar 31, 2025 | -8.40 Mn |
| Mar 31, 2025 | -8.40 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Sep 30, 2024 | 10.50 Mn |
| Jun 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 16.10 Mn |
| Mar 31, 2024 | 16.10 Mn |